PD-1 as an emerging therapeutic target in renal cell carcinoma: current evidence
Scott S Tykodi Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA Abstract: Renal cell carcinoma (RCC) is the most common primary malignant tumor of the kidney in adults, representing approximately 4% of all adult cancers in the United States. Metastat...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-07-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/pd-1-as-an-emerging-therapeutic-target-in-renal-cell-carcinoma-current-peer-reviewed-article-OTT |